DCOY
Decoy Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.69
−6.60%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-334.4%
Return on equity
-160.5%
Return on assets
-343.5%
Return on invested capital
0.00x
Asset turnover
-$8.3M
Cash from operations
$13
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026